Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer

Acta Oncologica

Volumn 40, Issue 5, 2001, Pages 588-592

  Yong Chan Ahn, ^a   Park, K ^a   Dae Yong Kim, ^a   Kwan Min Kim, ^a   Kim, J ^a   Young Mog Shim, ^a   Kyung Soo Lee, ^a   Han, J ^a   Ho Joong Kim, ^a   O Jung Kwon, ^a   Do Hoon Lim, ^a   Young Joo Noh, ^a   Jeong Eun Lee, ^a   Seung Jae Huh, ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; RADIATION; RADIOTHERAPY; TOXICITY; TUMORS;

CHEMORADIOTHERAPY;

ONCOLOGY;

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PATIENT COMPLIANCE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGITIS; ETOPOSIDE; FEMALE; HEMATOLOGIC DISEASES; HUMANS; LIFE TABLES; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034799775     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418601750444123     Document Type: Article

References (25)

1. Lung cancer in Korea (1980-1984)
2. Definitive radiotherapy and combined modality therapy for inoperable non-small cell lung cancer
3. Chemotherapy for advanced non-small cell lung cancer: How much benefit is enough?
4. Social and economic factors in the choice of lung cancer treatment
5. Inquiry about management of non-small cell lung cancer
6. Does knowledge guide practice? Another look at the management of non-small cell lung cancer
7. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805
8. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer
9. Carboplatin, etoposide, and radiotherapy, followed by surgery, for the treatment of marginally resectable non-small cell lung cancer
10. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)
11. Pre-operative concurrent chemoradiotherapy for stage IIIA (N2) non-small cell lung cancer
12. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer
13. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy
14. Enhancement of the potentiation of radiotherapy by platinum drugs in a mouse tumor
15. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
16. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer
17. The role of multimodality therapy in locoregional non-small cell lung cancer
18. Preoperative concurrent chemoradiotherapy for unresectable Stage III non-small cell lung cancer
19. Preoperative concomitant cisplatin/VP16 and radiotherapy in stage III non-small cell lung cancer
20. Accelerated induction therapy and resection for poor prognosis stage III non-small-cell lung cancer
21. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IlIA non-small-cell carcinoma of the lung: Report of a cancer and leukemia group B phase II study
22. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with respectable cancer of the lung
23. The role of surgery in N2 lung cancer
24. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan
25. Primary tumors and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: Serial CT findings with pathologic correlation